18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: Initial UK experience from a technologist's perspective

Nuclear Medicine Communications

Volumn 34, Issue 6, 2013, Pages 601-608

  Meintjes, Marguerite ^a   Endozo, Raymond ^a   Dickson, John ^a   Erlandsson, Kjel ^a   Hussain, Khalid ^a   Townsend, Caroline ^a   Menezes, Leon ^a   Bomanji, Jamshed ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

18F DOPA; congenital hyperinsulinism; PET imaging

Indexed keywords

CHLORAL HYDRATE; DIAZOXIDE; IODINATED CONTRAST MEDIUM; LEVO DIHYDROXYPHENYLALANINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 6 FLUORODOPA F 18; DOPA; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL DISORDER; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DRUG ACCUMULATION; DRUG MEGADOSE; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HYPERINSULINISM; HYPOGLYCEMIA; INFANT; INFORMATION PROCESSING; MALE; MOLECULAR IMAGING; PANCREAS; PANCREAS RESECTION; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RADIOLOGICAL TECHNOLOGIST; SCHOOL CHILD; SEDATION; SYNTHESIS; UNITED KINGDOM; ANALOGS AND DERIVATIVES; CLINICAL LABORATORY PERSONNEL; GREAT BRITAIN; MULTIMODAL IMAGING; NEWBORN; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PROCEDURES; RETROSPECTIVE STUDY; SCINTISCANNING; LABORATORY PERSONNEL; METHODOLOGY;

CHILD; CHILD, PRESCHOOL; CONGENITAL HYPERINSULINISM; DIHYDROXYPHENYLALANINE; FEMALE; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICAL LABORATORY PERSONNEL; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84876991192     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32836069d0     Document Type: Article

References (10)

1. Ismail D, Hussain K. Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism. Rev Endocr Metab Disord 2010; 11:165-169.
2. Fekete CN, de Lonley P, Jaubert J, Rahier J, Brunelle F, Saudubray JM. The surgical management of congenital hyperinsulinemic hypoglycaemia in infancy. J Pediatr Surg 2004; 39:267-269.
3. Ribeiro MJ, Del Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, et al. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nucl Med 2005; 46:560-566.
4. Barthlen W, Blankenstein O, Mau HW, Koch M, Hohne C, Mohnike W, et al. Evaluation of (18F)fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism. J Clin Endocrinol Metab 2008; 93:869-875.
5. Otonkoski T, Nanto-Salonem K, Seppanen M, Veijola R, Huopio H, Hussain K, et al. Noninvasive diagnosis of focal hyperinsulinism of infancy with 18F-DOPA positron emission tomography. Diabetes 2006; 55:13-15.
6. De Lonlay P, Simon-Carre A, Ribeiro MJ, Boddaert N, Giurgea I, Laborde K, et al. Congenital hyperinsulinism: pancreatic (18F)fluoro- Ldihydroxyphenylalanine (DOPA) decarboxylase and insulin secretion. J Clin Endocrinol Metab 2006; 91:933-940.
7. Jager PL, Chirakal R, Marriott CJ, Brouwers AH, Koopmans KP, Gulenchyn KY. 6-L-18F-Fluorodihydroxyphenylalanine PET in neuroendocrine tumours: basic aspects and emerging clinical applications. J Nucl Med 2008; 49:573-586.
8. Mohnike K, Blankenstein O, Christesen HT, De Lonlay J, Hussain K, Koopmans KP, et al. Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism. Horm Res 2006; 66:40-42.
9. Hardy OT, Hernandez-Pampaloni M, Saffer JR, Scheurmann JS, Ernst LM, Freifelder R, et al. Accuracy of (18F) fluoroDOPA positron emission tomography for diagnosis and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab 2007; 92:4706-4711.
10. Kapoor RP, James C, Hussain K. Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. Nat Clin Pract Endocrinol Meatab 2009; 5:101-112.